Account
Case Study
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their PUMA product as payers were not recognizi...

Read more
Case Study
26.04.2023
Developing a pharmacy submission pack

Our client wanted to broaden access and funding for their reproduction biosimilar in the UK. However...

Read more
Case Study
26.04.2023
Determining the UK pricing and access strategy

Our client is developing an innovative medical device for use in Type 2 diabetes (T2D). The client w...

Read more
Case Study
26.04.2023
Gaining payer insights into pricing, reimbursement

Our client has developed an innovative digital health platform to prevent falls. Due to the platform...

Read more
Case Study
26.04.2023
Communicating the value of a digital nutritional

Our client felt that their current value proposition was insufficient in communicating the benefits ...

Read more
Case Study
26.04.2023
Managing EMA parallel scientific advice process

Our client wanted to undertake joint payer scientific advice between the EMA and 5 national HTA bodi...

Read more
Case Study
26.04.2023
Development and refinement of payer value messages

Conduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...

Read more
Case Study
26.04.2023
Undertaking a NICE advice procedure

Our client had concerns as to whether the clinical end-points in their phase III trial were relevant...

Read more
Case Study
26.04.2023
Optimising trial design through the EUnetHTA

Our clients have been developing new drugs for crowded, rapidly evolving therapy areas, with uncerta...

Read more
Case Study
26.04.2023
Obtaining payer scientific advice

Our client was seeking to launch and in-licensed product in the EU, following launch in the US.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.